ENvue Medical Inc. (FEED)
NasdaqCM: FEED
· Real-Time Price · USD
0.34
-0.03 (-8.11%)
At close: Aug 28, 2026, 3:59 PM
0.36
+4.50%
After-hours: 7:58 PM
The price, the headline numbers and the latest news, in one place.
ENvue Medical Inc. (FEED) Stock Price, Analysis & Data
-8.11% (1D)
| Bid | 0.24 |
| Market Cap | 3.82M |
| Revenue (ttm) | 1.93M |
| Net Income (ttm) | -49.19M |
| 1.35 | |
| -25.22 | |
| n/a | |
| n/a | |
| P/B (ttm) | 0.04 |
| P/S (ttm) | 1.98 |
| Earnings Date | n/a |
| Ask | 0.43 |
| Volume | 464,956 |
| Avg. Volume (20D) | 1,210,752 |
| Open | 0.34 |
| Previous Close | 0.37 |
| Day's Range | 0.33 - 0.35 |
| 52-Week Range | 0.29 - 17.40 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About FEED
ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and disc...
Industry Medical Devices
Sector Healthcare
IPO Date May 28, 2015
Employees 12
Stock Exchange NasdaqCM
Ticker Symbol FEED
Website https://envuemed.com
Financial Performance
In 2025, ENvue Medical's revenue was 2.55M, a decrease of -0.2% compared to the previous year's 2.56M. Earnings were -18.18M, an increase of 390.82%.
Financial StatementsEarnings Surprise
ENvue Medical has released their quarterly earnings on Nov 19, 2019:
- Revenue of $653K misses estimates by $0, with -36.29% YoY decline.
- EPS of -264 exceeds estimates by 176.00, with 65.71% YoY growth.
